I've forgotten to add RoW, which would quickly follow US.
So, let's say one month after US.
No wonder poor SI looked so knackered.
Imagine SI & board working overtime on each of the above items.
Take one item, let's say item #4 - approval of Rem-L for Covid-19 ARDS.
What decisions & activities required prior to this?
In no particular order:
Agreed approach within Mesoblast
Pathway with FDA
Agreement with NIH
Compassionate use
Trial design
Media/ interviews
CR prep
CR execution
Manufacturing discussions
Discussions with various governments
...
I'm already tired, and that just to type it out LOL
SI, board & management would be and will be working overtime with the above milestone list to ensure each step/ decision is found & cohesive...
That's no easy feat!
Just think about it.
Well done Mesoblast & keep going!
-
- There are more pages in this discussion • 490 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100915 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 99 | 1 |
View Market Depth
| Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |